Anlotinib as a third-line or further treatment for recurrent or metastatic nasopharyngeal carcinoma: a single-arm, phase 2 clinical trial.

Saved in:
Bibliographic Details
Title: Anlotinib as a third-line or further treatment for recurrent or metastatic nasopharyngeal carcinoma: a single-arm, phase 2 clinical trial.
Authors: Fang, Yu1,2,3 (AUTHOR), Su, Ning1,2,4 (AUTHOR), Zou, Qihua1,2 (AUTHOR), Cao, Yi1,2 (AUTHOR), Xia, Yi1,2 (AUTHOR), Tang, Linquan2,5 (AUTHOR), Tian, Xiaopeng1,2 (AUTHOR), Liu, Panpan1,2 (AUTHOR), Cai, Qingqing1,2 (AUTHOR) caiqq@sysucc.org.cn
Source: BMC Medicine. 11/7/2023, Vol. 21 Issue 1, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 173470915
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Anlotinib as a third-line or further treatment for recurrent or metastatic nasopharyngeal carcinoma: a single-arm, phase 2 clinical trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Fang%2C+Yu%22">Fang, Yu</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Su%2C+Ning%22">Su, Ning</searchLink><relatesTo>1,2,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zou%2C+Qihua%22">Zou, Qihua</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cao%2C+Yi%22">Cao, Yi</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Xia%2C+Yi%22">Xia, Yi</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tang%2C+Linquan%22">Tang, Linquan</searchLink><relatesTo>2,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tian%2C+Xiaopeng%22">Tian, Xiaopeng</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Panpan%22">Liu, Panpan</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cai%2C+Qingqing%22">Cai, Qingqing</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<i> caiqq@sysucc.org.cn</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22BMC+Medicine%22">BMC Medicine</searchLink>. 11/7/2023, Vol. 21 Issue 1, p1-10. 10p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=173470915
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s12916-023-03140-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 10
        StartPage: 1
    Titles:
      – TitleFull: Anlotinib as a third-line or further treatment for recurrent or metastatic nasopharyngeal carcinoma: a single-arm, phase 2 clinical trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Fang, Yu
      – PersonEntity:
          Name:
            NameFull: Su, Ning
      – PersonEntity:
          Name:
            NameFull: Zou, Qihua
      – PersonEntity:
          Name:
            NameFull: Cao, Yi
      – PersonEntity:
          Name:
            NameFull: Xia, Yi
      – PersonEntity:
          Name:
            NameFull: Tang, Linquan
      – PersonEntity:
          Name:
            NameFull: Tian, Xiaopeng
      – PersonEntity:
          Name:
            NameFull: Liu, Panpan
      – PersonEntity:
          Name:
            NameFull: Cai, Qingqing
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 11
              Text: 11/7/2023
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 17417015
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BMC Medicine
              Type: main
ResultId 1